Clinical Trial: CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Newly Diagnosed Peripheral T-cell Lymphoma
Study Type: INTERVENTIONAL
Official Title: A Prospective, Single-arm, Multicenter Clinical Study of the Combination of CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma
Brief Summary:
Peripheral T-cell lymphoma (PTCL) is a highly heterogeneous and aggressive non-Hodgkin's lymphoma.The incidence rate of PTCL in China is much higher than the global average, and there is no unified standard treatment for initial PTCL.Currently, the CHOP regimen is widely used as first-line treatment.However, the overall response rate is still low, and effective therapies need to be explored.Epigenetics and genetics jointly determine critical features of tumors, and exploring new treatment strategies and…
Read more